Abstract
The evidence and guidelines presented in this article are meant to assist clinicians who manage children with FWS. However, physicians may choose to individualize therapy based on unique clinical circumstances or to adopt a variation of these guidelines based on a different interpretation of the evidence concerning these issues. No guidelines can eliminate all risk nor confine antibiotic treatment only to children likely to have occult bacteremia. The optimal management strategy reduces risk to a minimum at a reasonable cost and can be used in most practice settings.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
